Roux-en-Y gastric bypass outperforms sleeve gastrectomy in long-term hypertension remission

A systematic review of 11 randomized controlled trials involving 2,323 patients indicates that both sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) show comparable hypertension remission within the first four years post-surgery. However, RYGB demonstrated a significantly greater effectiveness in achieving remission at five years or more, with a relative risk of 1.39. These findings underscore the long-term advantages of RYGB in hypertension management, aiding surgical decision-making and patient counseling.